CBOE saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on February 14, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The 10-day RSI Indicator for CBOE moved out of overbought territory on February 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where CBOE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBOE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CBOE broke above its upper Bollinger Band on January 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on February 19, 2025. You may want to consider a long position or call options on CBOE as a result. In of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
CBOE moved above its 50-day moving average on January 27, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CBOE crossed bullishly above the 50-day moving average on January 31, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CBOE advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 246 cases where CBOE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.869) is normal, around the industry mean (5.532). P/E Ratio (25.769) is within average values for comparable stocks, (34.442). CBOE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.610). Dividend Yield (0.012) settles around the average of (0.030) among similar stocks. P/S Ratio (5.171) is also within normal values, averaging (112.357).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CBOE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
a provider of a marketplace for trading equity and index options
Industry InvestmentBanksBrokers
A.I.dvisor indicates that over the last year, CBOE has been loosely correlated with CME. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CBOE jumps, then CME could also see price increases.
Ticker / NAME | Correlation To CBOE | 1D Price Change % | ||
---|---|---|---|---|
CBOE | 100% | +0.97% | ||
CME - CBOE | 37% Loosely correlated | +0.22% | ||
SPGI - CBOE | 21% Poorly correlated | -0.38% | ||
ICE - CBOE | 20% Poorly correlated | +0.65% | ||
TW - CBOE | 20% Poorly correlated | +3.29% | ||
MDBH - CBOE | 20% Poorly correlated | -1.97% | ||
More |